Increased risk of chronic obstructive pulmonary disease in patients with schizophrenia: A population-based study

Psychosomatics

Volumn 54, Issue 4, 2013, Pages 345-351

  Hsu, Jer Hwa ^a   Chien, I Chia ^b,c   Lin, Ching Heng ^d   Chou, Yiing Jenq ^c   Chou, Pesus ^c  

^a Chia yi Hospital   (Taiwan)

^b Taoyuan Mental Hospital   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; POPULATION; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; TAIWAN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIPSYCHOTIC AGENTS; EPIDEMIOLOGIC METHODS; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCHIZOPHRENIA; SEX DISTRIBUTION; TAIWAN; YOUNG ADULT;

EID: 84880513910     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2012.08.003     Document Type: Article

References (38)

1. Halbert R.J., Isonaka S., George D., Iqbal A. Interpreting COPD prevalence estimates: what is the true burden of disease?. Chest 2003, 123:1684-1692.
2. Kuo L.C., Yang P.C., Kuo S.H. Trends in the mortality of chronic obstructive pulmonary disease in Taiwan, 1981-2002. J Formos Med Assoc 2005, 104:89-93.
3. Agustí A.G., Noguera A., Sauleda J., Sala E., Pons J., Busquets X. Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 2003, 21:347-360.
4. Chuang H.T., Mansell C., Patten S.B. Lifestyle characteristics of psychiatric outpatients. Can J Psychiatry 2008, 53:260-266.
5. Weber N.S., Cowan D.N., Millikan A.M., Niebuhr D.W. Psychiatric and general medical conditions comorbid with schizophrenia in the national hospital Discharge Survey. Psychiatr Serv 2009, 60:1059-1067.
6. Carney C.P., Jones L., Woolson R.F. Medical comorbidity in women and men with schizophrenia: a population-based controlled study. J Gen Intern Med 2006, 21:1133-1137.
7. Saha S., Chant D., McGrath J. A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?. Arch Gen Psychiatry 2007, 64:1123-1131.
8. Oud M.J., Meyboom de Jong B. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract 2009, 10:32.
9. Copeland L.A., Mortensen E.M., Zeber J.E., Pugh M.J., Restrepo M.I., Dalack G.W. Pulmonary disease among inpatient decedents: impact of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:720-726.
10. Chen W.L., Chen G.Y., Kuo C.D. Hypoxemia and autonomic nervous dysfunction in patients with chronic obstructive pulmonary disease. Respir Med 2006, 100:1547-1553.
11. Laurin C., Labrecque M., Dupuis G., Bacon S.L., Cartier A., Lavoie K.L. Chronic obstructive pulmonary disease patients with psychiatric disorders are at greater risk of exacerbations. Psychosom Med 2009, 71:667-674.
12. Frank T.L., Hazell M.L., Linehan M.F., Morris J.A., Frank P.I. The estimated prevalence of chronic obstructive pulmonary disease in a general practice population. Prim Care Respir J 2007, 16:169-173.
13. Menezes A.M., Perez-Padilla R., Jardim J.R., Muiño A., Lopez M.V., Valdivia G., et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005, 366:1875-1881.
14. Lindberg A., Jonsson A.C., Rönmark E., Lundgren R., Larsson L.G., Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005, 127:1544-1552.
15. Rönmark E., Lundbäck B., Jönsson E., Jonsson A.C., Lindström M., Sandström T. Incidence of asthma in adults-report from the obstructive Lung Disease in Northern Sweden Study. Allergy 1997, 52:1071-1078.
16. Himelhoch S., Lehman A., Kreyenbuhl J., Daumit G., Brown C., Dixon L. Prevalence of chronic obstructive pulmonary disease among those with serious mental illness. Am J Psychiatry 2004, 161:2317-2319.
17. Chien I.C., Chou Y.J., Lin C.H., Bih S.H., Chou P. Prevalence of psychiatric disorders among national health insurance enrollees in Taiwan. Psychiatr Serv 2004, 55:691-697.
18. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: a population-based prevalence study. JAMA 2000, 284:2606-2610.
19. O'Farrell T.J., Connors G.J., Upper D. Addictive behaviors among hospitalized psychiatric patients. Addict Behav 1983, 8:329-333.
20. Lyon E.R. A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv 1999, 50:1346-1350.
21. Barr A.M., Procyshyn R.M., Hui P., Johnson J.L., Honer W.G. Self-reported motivation to smoke in schizophrenia is related to antipsychotic drug treatment. Schizophr Res 2008, 100:252-260.
22. Dalack G.W., Healy D.J., Meador-Woodruff J.H. Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 1998, 155:1490-1501.
23. Compton M.T., Daumit G.L., Druss B.G. Cigarette smoking and overweight/obesity among individuals with serious mental illnesses: a preventive perspective. Harv Rev Psychiatry 2006, 14:212-222.
24. Franssen F.M., O'Donnell D.E., Goossens G.H., Blaak E.E., Schols A.M. Obesity and the lung: 5. Obesity and COPD. Thorax 2008, 63:1110-1117.
25. Gan W.Q., Man S.F., Senthilselvan A., Sin D.D. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580.
26. Almagro P., López García F., Cabrera F., Montero L., Morchón D., Díez J., et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med 2010, 104:253-259.
27. Yoshida T., Tuder R.M. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007, 87:1047-1082.
28. Chapman K.R. Chronic obstructive pulmonary disease: are women more susceptible than men?. Clin Chest Med 2004, 25:331-341.
29. Laniado-Laborín R. Smoking and chronic obstructive pulmonary disease (COPD). Parallel epidemics of the 21 century. Int J Environ Res Public Health 2009, 6:209-224.
30. Zhong N., Wang C., Yao W., Chen P., Kang J., Huang S., et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med 2007, 176:753-760.
31. Bang K.M., Syamlal G., Mazurek J.M. Prevalence of chronic obstructive pulmonary disease in the U.S. working population: an analysis of data from the 1997-2004. National Health Interview Survey COPD 2009, 6:380-387.
32. Soriano J.B., Maier W.C., Egger P., Visick G., Thakrar B., Sykes J., et al. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000, 55:789-794.
33. Tiengo A., Fadini G.P., Avogaro A. The metabolic syndrome, diabetes and lung dysfunction. Diabetes Metab 2008, 34:447-454.
34. Buse J.B., Cavazzoni P., Hornbuckle K., Hutchins D., Breier A., Jovanovic L. A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States. J Clin Epidemiol 2003, 56:164-170.
35. De Hert M., Schreurs V., Sweers K., Van Eyck D., Hanssens L., Sinko S., et al. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. Schizophr Res 2008, 101:295-303.
36. Olfson M., Marcus S.C., Corey-Lisle P., Tuomari A.V., Hines P., L'Italien G.J. Hyperlipidemia following treatment with antipsychotic medications. Am J Psychiatry 2006, 163:1821-1825.
37. Stang P., Lydick E., Silberman C., Kempel A., Keating E.T. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000, 117:354S-359S.
38. Bednarek M., Maciejewski J., Wozniak M., Kuca P., Zielinski J. Prevalence, severity and underdiagnosis of COPD in the primary care setting. Thorax 2008, 63:402-407.